Health - Google News: ArQule plunges on delay in cancer drug study - CBS News

Health - Google News Google News

ArQule plunges on delay in cancer drug study - CBS News Aug 29th 2012, 18:48 Proactive Investors USA & Canada ArQule plunges on delay in cancer drug study CBS News NEW YORK — Shares of ArQule Inc. plunged Wednesday after the company said one of its partners has stopped enrolling patients in a clinical trial of its cancer drug tivantinib. THE SPARK: ArQule's Japanese partner Kyowa Hakko Kirin Co. temporarily ... PropThink: ArQule Setback Increases Risk and Discount Rates for Forward RevenueReuters Why ArQule Shares NosedivedDailyFinance ArQule tanks after tox fears force a delay in Asian lung cancer studyFierceBiotech WKZO -Proactive Investors USA & Canada all 22 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: